Latest Announcement

Compremium Corp. Receives FDA clearance for the CPMX1 System

Switzerland based Compremium Corp. announces U.S. Food and Drug Administration FDA510k market clearance of its Compartmental Compressibility Monitoring System CPMX1.
Read

Unlocking Diagnostic Breakthroughs in Compressibility and Occlusion Pressure

Compressibility

Compressibility quantifies the degree to which tissue changes in response to pressure induced injuries.

Relative Compressibility: 15.4%

Normal
compressibility
.
Reduced
compressibility
Compressibility
ratio
Uncompressed state
Compressed state

A simple, yet powerful concept

Healthy compartments are more compressible than compartments at risk.

Compressibility versus pressure

Compressibility and pressure are in negative linear correlation.
Pressure

Vascular Occlusion Pressure

Occlusion pressure is the method of assessing pressure at the point of occlusion for any vessel of interest.

The Science

Compressibility is a simple yet immensely powerful tool that we are using to achieve more reliable diagnostics.

In clinical trials we’ve proven to be highly accurate in diagnosing certain musculoskeletal conditions.

97
%
sensitivity
98
%
specificity
Disclaimer
The CPMX1 has received FDA clearance for the following indication for use: “The Compartmental Compressibility Monitoring System (CPM#1)
is intended for real-time and intermittent monitoring of relative compartment compressibility.
The relative compartment compressibility (CP Value) is not meant for trend analysis.”
‍Healthcare professionals can apply to become an investigator and obtain the device for investigational use
by sending a request to info@compremium.ch

Partners

Great work is never done alone.